122 related articles for article (PubMed ID: 3879135)
21. Early prenatal diagnosis of 21-hydroxylase deficiency using amniotic fluid 17-hydroxyprogesterone determination and DNA probes.
Raux-Demay M; Mornet E; Boue J; Couillin P; Oury JF; Ravise N; Deluchat C; Boue A
Prenat Diagn; 1989 Jul; 9(7):457-66. PubMed ID: 2788885
[TBL] [Abstract][Full Text] [Related]
22. Neonatal screening for congenital adrenal hyperplasia using 17-hydroxyprogesterone assay in filter paper blood spots.
Larsson A; Hagenfeldt L; von Döbeln U; Curstedt T; Gustafsson J; Svensson E
Horm Res; 1988; 30(6):235-40. PubMed ID: 3250925
[TBL] [Abstract][Full Text] [Related]
23. Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program.
Cavarzere P; Camilot M; Teofoli F; Tatò L
Horm Res; 2005; 63(4):180-6. PubMed ID: 15818055
[TBL] [Abstract][Full Text] [Related]
24. Amniotic fluid concentrations of delta 5 and delta 4 steroids in fetuses with congenital adrenal hyperplasia due to 21 hydroxylase deficiency and in anencephalic fetuses.
Pang S; Levine LS; Cederqvist LL; Fuentes M; Riccardi VM; Holcombe JH; Nitowsky HM; Sachs G; Anderson CE; Duchon MA; Owens R; Merkatz I; New MI
J Clin Endocrinol Metab; 1980 Aug; 51(2):223-9. PubMed ID: 6447160
[No Abstract] [Full Text] [Related]
25. [Genetic counseling and prenatal diagnosis of adrenal hyperplasia caused by 21-hydroxylase deficiency].
Couillin P
Presse Med; 1984 Apr; 13(17):1087-90. PubMed ID: 6232534
[TBL] [Abstract][Full Text] [Related]
26. [Detection of heterozygotes in the classic type of congenital adrenal hyperplasia due to a 21-hydroxylase defect in our population as based on hormonal studies and HLA typing].
Dumić M; Tajić M; Brkljacić L; Mardesić D; Radica A; Lukenda M; Gjurić G; Jovanović V; Plavsić V; Kastelan A
Lijec Vjesn; 1984; 106(11-12):466-70. PubMed ID: 6335215
[No Abstract] [Full Text] [Related]
27. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.
Balsamo A; Cacciari E; Piazzi S; Cassio A; Bozza D; Pirazzoli P; Zappulla F
Pediatrics; 1996 Sep; 98(3 Pt 1):362-7. PubMed ID: 8784357
[TBL] [Abstract][Full Text] [Related]
28. Screening for late onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Khandekar S; Lata V; Dash RJ
Indian J Med Res; 1990 Apr; 92():79-82. PubMed ID: 2164496
[TBL] [Abstract][Full Text] [Related]
29. Morning salivary 17-hydroxyprogesterone is a useful screening test for nonclassical 21-hydroxylase deficiency.
Zerah M; Pang SY; New MI
J Clin Endocrinol Metab; 1987 Aug; 65(2):227-32. PubMed ID: 3496350
[TBL] [Abstract][Full Text] [Related]
30. Prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia by simultaneous radioimmunoassay of 21-deoxycortisol and 17-hydroxyprogesterone in amniotic fluid.
Gueux B; Fiet J; Couillin P; Raux-Demay MC; Mornet E; Galons H; Villette JM; Boue J; Dreux C
J Clin Endocrinol Metab; 1988 Mar; 66(3):534-7. PubMed ID: 3258316
[TBL] [Abstract][Full Text] [Related]
31. Circadian variation of plasma 17-hydroxyprogesterone among heterozygotic carriers of 21-hydroxylase deficiency (salt-losing form).
Urban MD; Migeon CJ; Lee PA
Horm Res; 1986; 23(2):74-7. PubMed ID: 3484712
[TBL] [Abstract][Full Text] [Related]
32. 21-Hydroxylase deficiency: HLA genotypes and hormonal phenotypes in the families of 32 Italian patients.
Livieri C; Belvedere M; Martinetti M; Beluffi G; Fiori P; Cogliati CR; Goffredo V; Lorini R; Severi F
Prog Clin Biol Res; 1985; 200():243-55. PubMed ID: 3001775
[No Abstract] [Full Text] [Related]
33. A neonatal mass-screening for congenital adrenal hyperplasia in Japan.
Shimozawa K; Saisho S; Saito N; Yata J; Igarashi Y; Hikita Y; Irie M; Okada K
Acta Endocrinol (Copenh); 1984 Dec; 107(4):513-8. PubMed ID: 6516697
[TBL] [Abstract][Full Text] [Related]
34. [Micro-filter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay. Application for diagnosis of 21-hydroxylase deficiency (author's transl)].
Shimozawa K; Tomita M; Nakagawa S; Saito Y; Sakurada N
Horumon To Rinsho; 1979 Sep; 27(9):1048-53. PubMed ID: 316748
[No Abstract] [Full Text] [Related]
35. A pilot study for neonatal screening of congenital adrenal hyperplasia due to 21-hydroxylase and 11-beta-hydroxylase deficiency in Campania region.
Valentino R; Tommaselli AP; Rossi R; Lombardi G; Varrone S
J Endocrinol Invest; 1990 Mar; 13(3):221-5. PubMed ID: 2365957
[TBL] [Abstract][Full Text] [Related]
36. Modern medical therapy of congenital adrenal hyperplasia. A decade of experience.
Winter JS; Couch RM
Ann N Y Acad Sci; 1985; 458():165-73. PubMed ID: 3879120
[No Abstract] [Full Text] [Related]
37. How reliable is newborn screening for congenital adrenal hyperplasia?
Pass KA
Nat Clin Pract Endocrinol Metab; 2006 Feb; 2(2):74-5. PubMed ID: 16932259
[No Abstract] [Full Text] [Related]
38. Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study.
Tsuji A; Konishi K; Hasegawa S; Anazawa A; Onishi T; Ono M; Morio T; Kitagawa T; Kashimada K
BMC Pediatr; 2015 Dec; 15():209. PubMed ID: 26671474
[TBL] [Abstract][Full Text] [Related]
39. Value of selective screening for congenital adrenal hyperplasia in Hungary.
Sólyom J; Hughes IA
Arch Dis Child; 1989 Mar; 64(3):338-42. PubMed ID: 2705794
[TBL] [Abstract][Full Text] [Related]
40. Amniotic fluid levels of 17 alpha-hydroxyprogesterone during human pregnancy: pre-natal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Wurster KG; Ranke MB; Heilbronner H; Gupta D
Endokrinologie; 1982 Oct; 80(2):142-50. PubMed ID: 6984387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
